A suitable skin booster may improve hydration where the chosen product supports that aim.
Consultation-led aesthetic medicine · Brighton & Hove · By appointmentConsultation-led · Brighton
HYDRATION · SMOOTHNESS · SKIN QUALITY
Skin BoostersHydration for softer, smoother skin.
For skin that feels less supple and looks finely creased or dull.Improving hydration can help it feel softer and look smoother.
At a glance
Hydration.
Smoother, softer skin.
Selected products may improve surface quality; the likely change depends on your skin and the treatment used.
The plan starts with the dryness, dullness or texture that concerns you and whether a skin booster could address it.
Your response is reviewed before deciding whether further treatment would be useful.
Quick overviewYour appointment at a glance
- Consultation
- I assess your skin and review your health history, medicines, allergies and previous treatments. We discuss whether a skin booster makes sense for you, including the proposed product, treatment area, risks and alternatives.
- Preparation
- Follow the preparation instructions agreed for your treatment. If your health, medicines or skin have changed since the consultation, let me know before your appointment.
- Treatment appointment
- I reassess the area before treatment, then inject the agreed product. Where and how much I inject follow the plan discussed with you.
- Recovery & aftercare
- Temporary injection-point bumps, redness, swelling, tenderness and bruising can occur. Their duration depends on product, area, amount, technique and your response. You receive advice on skincare, makeup, exercise and when to seek help.
- Sessions & review
- The usual starting plan is one to three appointments, four weeks apart. This is adjusted to the product, treatment area and your starting point. The proposed plan and review date are agreed before treatment.
- Continuing treatment
- The plan can continue, change or stop according to worthwhile benefit and your preferences. Daily care, another approach or more time may also be suitable.
The complete conversation
Your questions about
skin boosters
What skin boosters can change, what they cannot, and what to expect.
odNOVA guide
- 1You
- 2Piotr
- 3Clinical
- 4In depth
Choose a question
What are skin boosters?Piotr answers
Piotr
A skin booster is an injectable hyaluronic-acid treatment intended to improve hydration or other skin-quality features supported for that product. Its aim is different from filler used to build contour, projection or volume. Formulation and placement affect how it behaves.
How do skin boosters work?
Hyaluronic acid binds water. How an injectable behaves also depends on how that HA has been prepared.
Cross-linking joins HA chains together to form a gel. Some products used for skin quality contain cross-linked HA; others do not. Cross-linking is one part of the formulation, alongside HA concentration and the other ingredients.[10][6]
The distinction from structural filler is therefore not simply ‘cross-linked or not’. The product’s properties, the amount and where it is placed need to match the intended change. A skin-quality treatment aims to improve features such as hydration or smoothness; it is not selected to build cheek or chin projection.
Which concerns need a different approach?
Skin boosters are chosen for skin quality. Loss of facial support, hollows, cheek or chin projection and a lifting result need a plan directed at structure.[10]
Improving fine creasing is different from erasing established lines or correcting deeper acne scars. Active inflammation or a pigmentation concern needs its cause assessed before cosmetic treatment is considered.[9][11]
Treatment does not permanently stop skin ageing. The likely change depends on the product and your skin.
Are skin boosters fillers?
Some are. “Skin booster” describes a treatment aim, not one regulatory category. SKINVIVE, for example, is classified by the FDA as an injectable dermal filler. Here, I am using treatment to improve skin quality rather than build facial volume, support or contour. An injectable booster may create temporary local bumps or product presence, but its intended job is not to build facial shape. odNOVA also offers a Lip Booster. It is a skin-quality treatment, not a volumising lip filler, and it is not intended to add lip projection or change lip shape. The exact product and whether it is suitable for you are explained at consultation.
What do skin boosters do?Piotr answers
Piotr
Your skin may feel softer and look smoother or less finely creased. The change is usually subtle and depends on the product and your skin’s starting condition.
The realistic outcome
A study may detect a change with an instrument even when the person sees little difference. That is why I distinguish how your skin feels, what is visible and what a measurement shows.
The immediate appearance after injection is not the final result. We judge your response at the agreed review point.
Are skin boosters worth it?
Comparable photographs can make a review fairer: I look at the same concern rather than comparing different lighting or an early post-injection effect.
They can be worth considering if you want better hydration and a subtle improvement in skin quality. If you expect a significant lift or a change in facial shape, they will not meet that expectation.
The decision is whether the change matters to you enough to justify another appointment, its cost and its recovery.
Every maintenance appointment needs a reason.
Do skin boosters work?
Yes — some hyaluronic-acid skin boosters can improve hydration and selected measures of skin quality. The change is usually subtle.[4][6]
They are not a treatment I routinely recommend, and in most cases they would not be my starting point. I would first assess what your skin needs and whether another approach would offer more meaningful improvement.
How long do skin boosters take to work?
Results develop gradually over the following weeks. Minor swelling immediately after treatment is not the result. If your treatment involves a course of sessions, assess the response at the agreed review — not from the first appointment alone.
The timing depends on the product and course. Studies measure results at set visits; the change may become noticeable at a different point.[6][7][8]
How long do skin boosters last?
What should I look for in skin booster before-and-after photographs?
Look for the same lighting, angle and expression, with the treatment dates and number of sessions stated. Swelling immediately after injection is not the result.
A subtle change can be difficult to judge in a photograph. I compare the same concern under similar conditions and discuss what is realistically visible.
Why does my skin look dull, dry or tired — and could a skin booster help?Piotr answers
Piotr
A suitable skin booster may help your skin feel softer and look smoother or less finely creased. I first check whether hydration is part of the concern, because dryness, inflammation, pigment and changes in facial support need different approaches.
Skin quality is not one problem
Skin quality is useful shorthand, but it is not a diagnosis. Two people can both describe their skin as dry, dull or tired-looking while needing completely different things.
One may have a surface barrier problem. Another may have active inflammation. Another may be seeing fine texture made more visible by low hydration. Another may actually be noticing pigment, scarring or loss of facial support.
Those problems do not share one treatment.
I look at the condition of the skin, the pattern of the concern, current skincare, medical history, medicines, previous treatment and what change would matter to you. A booster only enters the discussion if hydration or another supported skin-quality property appears to be the correct target.
Diagnosis first. Even when the proposed treatment sounds simple.
What is causing the dryness?
Dryness can reflect a disrupted skin barrier, irritation or inflammation. A skin booster does not correct those underlying causes. The cause of the dryness needs to be established before injectable hydration is considered.
Daily care, removal of an irritant, sun protection or medical assessment may be more appropriate.
If the skin is healthy and the concern remains a subtle hydration or quality deficit, an injectable may become a reasonable option after assessment.
No treatment remains a route
No treatment is also a valid choice. It may mean giving healthy skin time, keeping daily care simple, or deciding that the likely benefit is not worth the treatment burden.
What does the current research actually show?Piotr answers
Piotr
Studies suggest that some injectable hyaluronic-acid products can improve hydration.[4] The evidence for other changes is more variable. Newer randomised trials support some products, but used no injection as their comparison, rather than a sham procedure. I look at the evidence for the product and area we are considering; it cannot predict exactly how your skin will respond.
Limits of the evidence
The studies used different products, treatment areas and ways of measuring change. This makes a single success percentage misleading.
No sham comparison supplied
The newer trials used no injection, not a sham procedure, so needling and treatment-context effects cannot be separated.
No universal head-to-head answer
The record does not compare every booster fairly with polynucleotides, microneedling, skincare or no treatment.
Product and site stay attached
One formulation, protocol or body area cannot prove another product, facial site or odNOVA service.
Measured is not automatically visible
Hydration, radiance, elasticity, patient impression and visible change are different endpoints.
All three compared treatment with no injection, rather than a sham procedure. They cannot separate the effect of the studied formulation from the effects of needling and the treatment setting. One research team states explicitly that the effect of needle insertion cannot be excluded.[6][7][8]
The trials took place in Chinese populations and each tested a different formulation. They strengthen the evidence for those products, but do not establish one success rate or treatment course for every skin booster. Studies of this size also cannot reliably measure rare vascular complications.
Some evidence comes from large randomised trials; other studies are small or observational. Hydration has the clearest support. Findings for texture, firmness or other changes depend on the specific product and how and when they were measured.
One study, one story
A study that measures water in the skin tells us something different from photographs or patient ratings. Changes measured by an instrument may be too subtle to see, and results from the upper arm do not establish a facial result. Each study summary below explains what was tested and found.
What is the evidence for the products I offer?
SKINVIVE: a randomised cheek study found improved smoothness compared with no treatment. Follow-up extended to six months, but the untreated comparison lasted only one month. That evidence covers this product and this area. Your own result may differ.[16]
BELOTERO Revive: the BELOVE study did not meet its main hydration endpoint across the full study population. A small dry-skin subgroup improved. A separate small split-face study found a greater instrument-measured pore-volume reduction than BELOTERO Soft, but no clear overall advantage in hydration or patient satisfaction. Each finding applies to the outcome that was measured.[17][23]
Sunekos: small studies of Sunekos 200 and a Performa-associated formulation reported changes in selected skin measures. They lacked untreated or sham-injection controls. Findings for one formulation do not establish the result of another.[18][19]
Jalupro: small, uncontrolled SuperHydro studies reported improvements in selected skin measurements. They do not prove that the treatment rebuilds facial ligaments, or establish the effects of Classic or HMW.[20][21]
Infini: I have not identified a product-matched human skin-quality trial in this review. The retrieved evidence remains incomplete. The exact formulation and intended route still need checking against the current product documents.
Clinical studies and reviews
The summaries below explain the findings and the limits of each study.
Research
Kerscher 2008 and Reuther 2010.[1][2]
selected instrument-measured skin properties changed after this specific product and protocol.
Study details and original results
Research card A — one small facial dataset reported twice
Studies: Kerscher 2008 and Reuther 2010.[1][2] Who and where: the same or an overlapping group of 19 women, with a specific stabilised non-animal HA product used in the lower cheeks. Study protocol: three sessions, four weeks apart. This is the research protocol, not a universal odNOVA course recommendation. What was done well: the investigators used defined products and objective biophysical measurements. Important limitation: 19 people is a very small sample, the work was open-label, there was no untreated comparison group, and the two papers are not independent replication. What a patient may infer: a measurable change is possible for that product, site and protocol. What a patient may not infer: a reliable visible result, a class-wide effect, an odNOVA-product result or a durable benefit across the face, neck, lips or any other area.
Research
Distante 2009.[3]
instrument-measured change was reported in upper-arm skin for the product studied.
Study details and original results
Research card B — a different body area
Study: Distante 2009.[3] Where: upper-arm skin, not facial skin. Why it matters: it shows that product-specific effects have been studied in a different site. Important limitation: upper-arm evidence is not facial evidence. Skin thickness, movement, vascular anatomy, treatment objectives and visible expectations differ. What a patient may infer: product-specific effects have been investigated outside the face. What a patient may not infer: that odNOVA offers that area, or that the result transfers to the face or another product.
Research
Ghatge and Ghatge 2023 systematic review.[4]
some studies reported improvements in hydration, elasticity, roughness or other skin-quality measures.
Study details and original results
Research card C — the wider evidence base
Study: Ghatge and Ghatge 2023 systematic review.[4] Included evidence: Most included studies were observational. Important limitation: the studies were generally small, products and protocols differed, outcomes were often subjective, most studies had a moderate risk of bias and long-term outcomes were missing. Patient translation: the literature supports the possibility of improvement. It does not support a guaranteed, uniform or long-lasting result across the whole category.
Research
Zhou and Yu 2025 systematic review and meta-analysis.[5]
pooled controlled data suggested improvement in hydration and radiance, but did not show a statistically significant improvement in elasticity or melanin index.
Study details and original results
Research card D — what later pooled evidence adds
Study: Zhou and Yu 2025 systematic review and meta-analysis.[5] Included evidence: 12 studies, with six providing data that could be pooled. Important limitation: products, protocols and outcomes differed, and the hydration estimate remained uncertain across studies. Patient translation: the wider signal is still property-specific. It does not prove that every HA-based booster improves every feature of skin quality or predict an odNOVA result.
Research
Cheng 2026 · 448 adults
Hydration and selected skin-quality measures improved against routine skincare without injection.
Study details and original results
Cheng 2026 · 448 adults
What was tested: three full-face sessions of one non-cross-linked hyaluronic-acid solution, 4 mL per session, at baseline, day 28 and day 56.[6] Comparator: routine skincare with no injection. What changed: hydration, elasticity and several assessor-rated outcomes favoured the studied treatment through 28 days after the final session. Boundary: this was one formulation in a Chinese population, against no injection rather than a sham procedure. It cannot predict another product or an individual odNOVA result. No serious adverse events were observed; the authors reported no funding or competing interests.
Research
Liao 2026 · 420 adults
Selected skin-quality improvements were reported against no intervention, with follow-up to six months.
Study details and original results
Liao 2026 · 420 adults
What was tested: three full-face sessions of one non-cross-linked hyaluronic-acid gel at three-week intervals.[7] Comparator: no intervention. What changed: the paper reported higher global aesthetic and dryness/dullness improvement rates, with selected effects reported through six months. Boundary: these improvement rates belong to that product, protocol, outcome definition and population; they are not a class-wide success rate. Reported adverse events were mild and transient. Two authors were employed by the manufacturer.
Research
Yang 2026 · 456 enrolled
Selected aesthetic ratings, hydration and elasticity favoured the studied formula against no intervention.
Study details and original results
Yang 2026 · 456 enrolled
Funding and author affiliations: funded by Bloomage Biotechnology Corporation Limited; two authors were employed by the company.[8]
What was tested: three monthly sessions of one sodium-hyaluronate composite containing four amino acids; 439 participants completed the study.[8] Comparator: no intervention. What changed: global aesthetic ratings, hydration and elasticity favoured the studied treatment, with selected effects reported through three months. Boundary: the result cannot be transferred to a different formula, protocol or patient. The safety findings apply to the studied formulation and protocol. Rare complications require evidence from much larger populations.
Is the evidence good?
The evidence supports improvement in selected skin-quality measures, particularly hydration, for some specific HA formulations. Newer large randomised trials strengthen that signal, but the evidence remains product-specific, often short and not consistently placebo-controlled. It does not provide a reliable class-wide percentage or guarantee a visible result for you.
How is this different from polynucleotides or microneedling?Piotr answers
Piotr
A skin booster is a hyaluronic-acid injectable chosen for a supported hydration or surface-quality objective. Polynucleotides use a different material, proposed biological rationale and evidence base. Microneedling uses controlled mechanical stimulation rather than leaving an injectable product in the skin. The choice depends on the concern being treated; shared terms such as ‘regeneration’ do not make these treatments interchangeable.
Skin booster versus other treatment families
Patients often encounter several services described with broad phrases such as skin quality, regeneration or collagen support. Those phrases can blur clinically different pathways.
| Treatment family | Primary decision question | Important boundary |
|---|---|---|
| Dermal filler | Is selected structural support, contour or volume the real objective? | A structural treatment should not be disguised as skin hydration. |
| Biostimulator | Is tissue support or a product-specific biostimulatory pathway the real target? | Different products behave differently, and some uses overlap with skin-quality goals. Assessment must resolve the overlap. |
| Microneedling or peel | Is resurfacing, selected texture, scarring or pigment the more relevant target? | These procedures create a different controlled skin response; they are not injectable hydration. |
Use this table to understand the options. Assessment determines which route fits your concern.
Alternatives, including no treatment
Depending on what assessment finds, alternatives may include:
- a better structured skincare plan;
- treatment of an active or underlying skin condition;
- sun protection and time;
- a resurfacing route for selected texture, scarring or pigment concerns;
- a structural treatment where loss of support is the real issue;
- another product-specific skin-quality or autologous pathway;
- surgical assessment where the concern is beyond a non-surgical treatment;
I choose the smallest plan that addresses the problem I find.
Skin booster or polynucleotides?
They are different treatment families with different materials and evidence. A booster may be considered for a product-supported skin-quality objective; a polynucleotide pathway has its own product-specific rationale and limitations. The correct question is which concern is present and which exact product has evidence for that use.
Are all skin boosters the same?Piotr answers
Piotr
No. Two products can both contain hyaluronic acid and still behave differently in the skin. Formulation, concentration and stabilisation matter, as do the amount and placement. The choice needs to match the treatment area and the change you want. The expected recovery and risks are discussed for the product being proposed.
Not every booster is the same
That means a study of one formulation in one part of the body cannot be used as proof for every booster, every face, every area or every commercial tier.
What should I know about the proposed product?
Ask which formulation I recommend, how much is proposed and why it fits the treatment area. Those details are more useful than a general label such as Classic or Premium.
How do Classic and Premium differ?
Classic uses hyaluronic acid on its own. Premium combines hyaluronic acid with additional ingredients, such as vitamins and amino acids. The choice depends on your skin concern and the formulation. More ingredients do not automatically make a treatment more suitable for your skin.
The proposed plan explains the product and formulation, treatment area and purpose, amount, supporting evidence and expected change. The total cost and what is included are confirmed before you decide. A higher price does not guarantee a better result.
What is the best skin booster for my skin?
The consultation considers:
- what you mean by dry, dull, crepey or tired-looking skin;
- whether the skin is healthy enough for an elective injectable;
- whether the concern is mainly hydration, texture, pigment, inflammation or structure;
- relevant health conditions, allergies, medicines and previous injectables;
- the exact product and whether its intended use fits the proposed area;
- how subtle the likely outcome may be;
- whether skincare, another treatment family or no treatment is the better answer.
The recommendation should be explained before consent. If the product, purpose or evidence cannot be explained clearly, the decision is not ready.
Can a skin booster be used anywhere on the face or body?
No. Not every product is suitable for every area. The treatment area must match the chosen formulation and its intended use. A result shown in one part of the body does not establish the same result elsewhere.
What about Profhilo, Seventy Hyal, Sunekos and the other names?
They are not interchangeable, and some of them are not skin boosters at all.
Several products marketed under their own names are hyaluronic-acid injectables aimed at skin quality. They differ in concentration, whether the HA is stabilised, what else is in the formulation and how they are meant to be placed. A result published for one does not establish a result for another.[10][12][13]
Others sit in different treatment families altogether. Polynucleotide products use a different material and a different proposed rationale. Topical serums sold with similar names are not injectables at all.
Names you may encounter include LUMI-PRO, Seventy Hyal 2000, Profhilo, Hyaron, Jalupro, STYLAGE HydroMax, Sunekos, SKINVIVE and BELOTERO Revive. The name alone does not tell you whether a particular formulation fits your skin.
What I offer, and what I do not: At odNOVA I use Infini, Sunekos, Jalupro, SKINVIVE and BELOTERO Revive. The precise formulation is selected at consultation. I do not offer LUMI-PRO or Profhilo.
If you have read about a specific product and want to know whether it fits your concern, bring the name to the consultation. The useful conversation is about what you want changed, not which brand you arrived with.
Does FDA approval tell me which skin booster to choose?
FDA approval concerns a specific product and use in the United States. It is not a blanket approval for a brand or every treatment area. SKINVIVE has FDA-approved uses for improving cheek skin smoothness and, since June 2026, reducing neck lines in adults over 21.[12][22]
For treatment in England, I also need to consider the applicable UK requirements, the exact product’s instructions, evidence and source of supply. “FDA registered” is not the same as “FDA approved”.[14][15]
Am I suitable, or should this wait?Piotr answers
Piotr
Active infection, a cold sore or inflammation in the treatment area may mean postponing treatment. Skin Boosters are not offered during pregnancy or breastfeeding. Suitability also depends on the product, your health, medicines, allergies, healing and any previous injectables in the area.
Suitability and reasons to postpone
Assessment must also consider:
- allergies or hypersensitivity relevant to the exact product or any component used during treatment;
- autoimmune or connective-tissue disease, particularly active disease;
- bleeding disorders or medicines that affect bleeding;
- previous injectables, permanent material or an unknown product in the area;
- a history of severe allergy, abnormal scarring or healing concerns;
- whether the expected result matches the real clinical problem.
Can I have skin boosters during pregnancy or breastfeeding?
No. I do not offer skin booster treatment during pregnancy or breastfeeding.
Can skin boosters be used under the eyes?
Yes, in selected cases. The exact product needs to suit this area; a formulation used on the cheeks is not automatically appropriate under the eyes.
I first distinguish a skin-quality concern from hollowing, pigment, puffiness or loose skin. These do not all need the same treatment. A skin booster is not a substitute for correcting a structural problem.
A small Sunekos 200 study reported improvements in periorbital wrinkle and dark-circle scores. It had no control group, only 23 of 35 participants completed it, and the manufacturer funded it. That supports a cautious discussion in selected cases; it leaves considerable uncertainty.[24]
What can go wrong, and what needs urgent action?Piotr answers
Piotr
Most visible effects are temporary: injection-point bumps, redness, swelling, tenderness or bruising. More persistent swelling, lumps, infection, cold-sore reactivation or an inflammatory reaction needs review. Rare vascular injury is urgent: increasing or severe pain, skin turning pale, white, dusky or mottled, blistering or cold skin needs urgent assessment; a sudden change in vision or severe eye pain needs emergency medical help: go to A&E or call 999; do not wait for a clinic reply.
Risks and urgent warning signs
Possible effects of an injectable HA skin-quality procedure include pain or stinging, temporary bumps, redness, swelling, warmth, tenderness, bruising and itching. Other possible problems include prolonged swelling, persistent lumps or uneven texture, infection, cold-sore reactivation and hypersensitivity or inflammatory reactions.
Facial injections also carry a rare but serious risk of vascular injury. Depending on the area involved, this can damage skin or affect vision.
The exact frequencies are not reliably established across every product, area and technique. They should not be described as universal percentages.
Increasing or severe pain, skin that becomes pale, white, dusky or mottled, blistering or a cold area requires urgent assessment. A sudden change in vision or severe eye pain needs emergency medical help: go to A&E or call 999. Do not drive yourself or wait for a clinic reply. General web copy is not a substitute for individual aftercare or emergency advice.
Does Lip Booster need different advice?
Yes. The lips need an area-specific plan, consent and recovery advice. General information about facial skin boosters does not replace those instructions. Read the warning signs that need urgent help.
What happens at the consultation — and at the treatment itself?Piotr answers
Piotr
The consultation covers your skin concerns, health, medicines, allergies and previous treatments. If a skin booster is suitable, the product, treatment area, expected changes, risks and alternatives are explained before you decide.
At the treatment appointment, the area is checked again before the injections. The amount and placement are chosen for the product and your anatomy. A consultation booking does not include treatment; a treatment appointment can proceed only if the assessment confirms suitability.
Do I need to choose a product beforehand?
No. The choice depends on your skin, the treatment area and the change you want. The suitable options are explained during the consultation before a product is chosen.
Do skin boosters hurt?Piotr answers
What might I notice after treatment?Piotr answers
Piotr
Bruising can occur at the injection sites. If you have an important event coming up, mention it before choosing your appointment date.
What should I avoid after skin boosters?
Do not rub, scrub or massage the treated area unless I have specifically advised it for your product. Follow the individual instructions about skincare, make-up, exercise and heat exposure.
The answers below describe the practical advice discussed for my clinic. A longer interval in your product-specific instructions takes priority.
Do not stop prescribed blood-thinning or other medicine for an elective procedure unless the prescriber responsible for it has advised you to do so.
Exact aftercare timings belong to the selected product and clinic protocol. They are not universal skin-booster facts.
How long do bumps last after skin boosters?
The small bumps mark where the product has been deposited under the skin. In my practice, they usually settle within 24 hours, although they can take up to three days.
This is the usual recovery discussed for the planned treatment. Other reactions can last longer. Persistent or worsening changes need assessment.
Can I wash my face after a skin booster treatment?
Yes, absolutely — you can gently wash your face later the same day. Use a mild cleanser and lukewarm water, without unnecessary rubbing or scrubbing.
When can I wear make-up after skin boosters?
Wait a full 24 hours before applying make-up — not simply until the next morning. This is the aftercare interval I use in my clinic.
When can I exercise after skin boosters?
Wait at least 24 hours before strenuous exercise, including weight training. If swelling or tenderness remains, wait longer.
How many skin booster sessions do I need?Piotr answers
Piotr
The usual starting plan is one to three appointments, four weeks apart. This is adjusted to the product, treatment area and your starting point. The proposed plan and review date are agreed before treatment. Further appointments depend on your response and what the treatment is intended to maintain.
Courses, review and maintenance
Before treatment, you should understand:
- why that product and plan were chosen;
- how response will be judged;
- when the plan will be reviewed;
- what happens if benefit is too small;
- whether treatment can stop or change;
- what later maintenance would be trying to preserve.
How often should I have skin boosters?
My usual starting plan is one to three appointments, four weeks apart, adjusted to the product and your skin. That is the initial course. Maintenance is decided separately.
Further appointments depend on your response and whether the benefit justifies repeating treatment. I do not book maintenance simply because a set number of months has passed.
What if I see no improvement after skin boosters?
Skin boosters aim for subtle improvement. One session may make little visible difference. The difference you notice depends on your skin’s starting condition.
If you see no improvement, contact me for review. I reassess the original concern and the response before recommending more treatment. The next step may be to adjust the plan, choose another approach or stop.
How much do skin boosters cost?Piotr answers
Piotr
Each appointment is paid for separately. Further treatment is considered after review, and you can stop at any point. The proposed product, amount, treatment area and cost are confirmed before you decide. See the Fees page for current prices.
Question index
All your questions, by topic.
Open a topic and choose a question to go straight to its answer.
Browse all 43 questions
Products and how they differ10 questions
Results and evidence9 questions
Skin concerns and alternatives5 questions
Suitability and safety6 questions
Consultation and appointment3 questions
After treatment, sessions and fees10 questions
References & sources
These studies show what specific products achieved—not what every skin booster can do, or what result you will get.
View all 24 references
- Kerscher M, Bayrhammer J, Reuther T. NASHA / Restylane Vital. PMID 18384619. DOI 10.1111/j.1524-4725.2008.34176.x. Small open-label lower-cheek study. The product studied does not identify what odNOVA uses. PubMed
- Reuther T, Bayrhammer J, Kerscher M. NASHA / Restylane Vital. PMID 19730872. DOI 10.1007/s00403-009-0988-9. Same or overlapping 19-person cohort; not independent replication. The product studied does not identify what odNOVA uses. PubMed
- Distante F, Pagani V, Bonfigli A. PMID 19207331. DOI 10.1111/j.1524-4725.2008.01051.x. Upper-arm intradermal study; not facial or service-availability evidence. PubMed
- Ghatge AS, Ghatge SB. Systematic review. PMID 37038447. DOI 10.2147/CCID.S404248. Heterogeneous, predominantly observational evidence and no reliable long-term conclusion. PubMed
- Zhou R, Yu M. Systematic review and meta-analysis. PMID 39807700. DOI 10.1111/jocd.16760. 12 studies, 6 pooled; hydration and radiance signal, with elasticity and melanin index non-significant. PubMed
- Cheng H, Jiang M, Zhong S, Liu X, Cao D, Feng Q, Li Y, Xu W. Prospective multicentre randomised assessor-blinded trial; 448 enrolled; ChiCTR2300078169. PMID 41971651. DOI 10.2147/CCID.S590699. No funding and no competing interests reported. PubMed
- Liao Z, Hong W, Wang S, Hou Y, Lu S, Chen R, Zhang Y, Chen J, Liu Y, Luo S. Dermatologic Surgery 52(8):776–782. PMID 41650338. DOI 10.1097/DSS.0000000000005042. Two authors were employed by Hyamed Biotechnology. PubMed
- Yang R, Zhang Y, Zhao H, et al. 2:1 no-intervention comparator; 456 enrolled and 439 completed; sodium-hyaluronate composite containing glycine, proline, leucine and lysine. PMID 42367716. DOI 10.1097/GOX.0000000000007853. Funded by Bloomage Biotechnology Corporation Limited; two authors were employed by that company. PubMed
- Product information: SKINVIVE by JUVÉDERM, Patient Information Labeling, sections 2, 9 and 10, and the treatment precautions. Cited for injection discomfort, a formulation containing local anaesthetic and active-inflammation precautions; this US product-specific document does not identify the product or comfort protocol used at odNOVA. FDA patient information (accessed 8 October 2026).
- Formulation: US Food and Drug Administration. SKINVIVE by JUVÉDERM, Summary of Safety and Effectiveness Data, P110033/S099, section V: Device Description (2026). Cited as an example of a cross-linked HA formulation used for skin quality; this product-specific source does not identify the product used at odNOVA. FDA SSED (accessed 8 October 2026).
- Clinical guidance: American Academy of Dermatology. Melasma: Diagnosis and treatment. Cited for assessing the cause of a pigmentation concern and choosing treatment accordingly; not evidence of skin-booster efficacy. AAD patient guidance (accessed 8 October 2026).
- US FDA. SKINVIVE by JUVÉDERM — P110033/S059. Product-specific cheek indication, safety and labelling. Source
- Merz Aesthetics. BELOTERO Revive international English Instructions for Use. Formulation and safety information; not verified as the current Great Britain version. Source
- MHRA. Regulating medical devices in the UK. Great Britain requirements are separate from US approval. Source
- US FDA. FDA registration and listing do not mean product approval, clearance or authorisation. Source
- Alexiades et al. Randomised VYC-12L / SKINVIVE cheek-smoothness study; manufacturer-sponsored, no-treatment rather than sham control. Source
- Kerscher et al. BELOVE / CPM-HA20G. Negative full-population primary hydration endpoint; small dry-skin subgroup finding. Merz-sponsored. Source
- Sparavigna and Orlandini 2017. Sunekos 200 open-label facial study; no control; manufacturer-affiliated coauthor. Source
- Fasola and Kutera 2022. HY6AA+ pilot associated with Performa; ten women, uncontrolled, inconsistent follow-up descriptions. Source
- Shelemba et al. Jalupro SuperHydro observational study, 28 women; material supplied by manufacturer. Source
- Poleva. Jalupro SuperHydro retrospective study, 43 adults; no control; product supplied by manufacturer. Source
- FDA. SKINVIVE P110033/S099 SSED, June 2026: additional neck-lines indication. US indication, not a UK instruction. Source
- Rutnumnoi et al. 2025. Randomised split-face comparison of BELOTERO Revive and Soft, 30 enrolled / 29 completed. Small active-comparator study; Merz supplied the products. Primary study
- Kabakci et al. 2023. Sunekos 200 periorbital uncontrolled study; 35 enrolled, 23 completed; manufacturer-funded. Primary study
This page provides general information. It cannot determine individual suitability and does not replace medical assessment, consent or treatment-specific aftercare.